Search
Selected: All

Use of .DELTA.5 androstenes in the treatment of HIV wasting synd

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 17β-dihydroequilenin as an antioxidant

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 19-nor-4-androstenediol to increase 19-nortestosterone le

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 2,5-dihydroxybenzenesulphonic acid in the production...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 3-methoxy-pregnenolone in the production of a...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 4-androstene-3alpha,17 beta-diol to increase...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 4-androstenediol to increase testosterone levels in human

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 4-cholesten-3-one as an anti-obesity agent

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 5-alpha-androst-1-en-3,17-dione to increase the level...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 5alpha-androstanediol or 5alpha-androstanedione to...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 7 &agr;-substituted steroid to treat...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of a pregnane derivative

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of a stanol fatty acid ester for reducing serum cholesterol

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of agonists of the glucocorticosteroid and/or...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of aldosterone antagonists to inhibit myocardial fibrosis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of aldosterone antagonists to inhibit myocardial fibrosis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of aldosterone antagonists to inhibit myocardial fibrosis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of aldosterone antagonists to inhibit myocardial fibrosis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of aldosterone antagonists to inhibit myocardial fibrosis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of aldosterone antagonists to inhibit myocardial fibrosis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.